SciELO - Scientific Electronic Library Online

 
vol.42 número1Estimación del punto de corte de la circunferencia abdominal como criterio diagnóstico del síndrome metabólicoImportancia de la sacarosa para la cicatrización de heridas infectadas índice de autoresíndice de assuntospesquisa de artigos
Home Pagelista alfabética de periódicos  

Serviços Personalizados

Artigo

Indicadores

  • Não possue artigos citadosCitado por SciELO

Links relacionados

  • Não possue artigos similaresSimilares em SciELO

Compartilhar


Revista Cubana de Medicina Militar

versão impressa ISSN 0138-6557

Resumo

INFANTE VELAZQUEZ, Mirtha et al. Endoscopic variceal ligation plus propranolol for secondary prophylaxis of gastrointestinal bleeding in cirrhotic patients. Rev Cub Med Mil [online]. 2013, vol.42, n.1, pp. 39-48. ISSN 0138-6557.

Introduction: the combination of endoscopic ligation of esophageal varices along with beta blockers drugs is the treatment of choice for secondary prophylaxis of bleeding. Objective: to determine the probability of occurrence of an episode of recurrent bleeding in a group of patients who received a combination therapy, and if this recurrence is related or not to the cause of cirrhosis or to the degree of hepatocellular dysfunction. Methods: adescriptive, prospective and longitudinal study was conducted. Survival curves were constructed taking as rebleeding as an event. Comparison was performed according to the cause and disease status according to Child-Pugh stage. Results: 23 patients were included: 56.5 % male and 43.5 % female. The main cause of cirrhosis was hepatitis C virus infection (52.2 %). Seven patients (30.4 %) were in stage A of Child; 10 (43.5 %) in B and 6 (26.1 %) in C. 3.47 average ligation sessions were performed and 97.39 mg was the mean dose of propranolol administered. All patients had their varices eliminated. The overall rebleeding rate was 13.04 %. 34.8 % of cases suffered worsening or occurrence of hypertensive gastropathy. The cumulative probability of survival was 95.2 % at three months, 87.9 % at 11 months and 79.1 % at 14 months. No differences in survival were found related to the cause (p = 0.749), but there were found differences according to Child stage (p = 0.002). Conclusions: the assessed combination therapy is useful to eliminate and prevent recurrent variceal bleeding.

Palavras-chave : cirrhosis; banding; esophageal varices; propranolol.

        · resumo em Espanhol     · texto em Espanhol     · Espanhol ( pdf )